Skip to main content

Align Technology statistics

  • ALGN · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$168.32+0.81%Close 13 Nov 2026 · Market value $11.85B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Align Technology is valued at $11.85B on its latest close. Its price is 24.1 times its earnings.

Market value$11.85B
Enterprise value$10.90B
Price / earnings24.09
Price / sales2.85
Price / book2.75
EV / EBITDA12.70
EV / sales2.62
Price / free cash flow19.66
Price / free cash flow, own 5-year average36.74
EV / EBIT17.48
EV / free cash flow18.01
Free cash flow yield5.1%

Share price

Latest close$168.32
Day's change+0.8%
52-week high$200.44
52-week low$130.23
From 52-week high−16.0%
Return · 1 month+14.3%
Return · 3 months+5.9%
Return · year to date+7.8%
Return · 1 year+18.8%
Beta · 1 year against the S&P 5001.31
50-day average$151.67
200-day average$168.68
RSI 1461.2
Average volume · 20 sessions1.2M

Margins and returns

For fiscal 2025, as filed.

Gross margin67.2%
Operating margin13.5%
Net margin10.2%
Free cash flow margin12.2%
Return on equity10.4%
Return on assets6.1%
Return on invested capital8.5%
Return on invested capital, 5-year average11.5%
Return on capital employed12.9%
Stock-based compensation / revenue4.6%

Financial position

At the end of fiscal 2025.

Cash and equivalents$1.09B
Total debt$114.4M
Net debt−$980.5M
Current ratio1.36
Quick ratio1.21
Debt / equity0.03
Net debt / EBITDA−1.25

Growth

Revenue, latest quarter on a year+1.9%
Revenue, twelve months on a year+4.4%
EPS, latest quarter on a year+144%
EPS, twelve months on a year+33.3%
Revenue, 5-year compound+10.3%
Revenue, 10-year compound+16.9%
Net income, 5-year compound−25.4%
Free cash flow, 5-year compound−0.7%
EPS, 5-year compound−24.1%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares72.6M
Shares outstanding, 5-year compound−1.7%
Net share repurchases$444.2M

Taxes

For fiscal 2025, as filed.

Income tax expense$174.9M
Effective tax rate29.9%

ALGN in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.